FOR THE RECORD: This story originally published an incorrect photo for Kristina Trujillo, a research assistant professor at UNM’s Health Sciences Center whose cancer-fighting technology is the basis of a new company, ExoVita Biosciences Inc.
The New Mexico Start-Up Factory announced Wednesday it has launched ExoVita Biosciences, Inc., which is developing cancer treatments based on technology developed by a University of New Mexico professor.
The treatments enlist the body’s own defenses in eliminating cancerous growths, according to a news release.
The technology was developed by Kristina Trujillo, PhD, a research assistant professor in the Department of Biochemistry and Molecular Biology at the UNM’s Health Sciences Center.
ExoVita has an exclusive option-to-license agreement for the technology with STC.UNM, the university’s technology transfer and economic development organization.
Trujillo’s research focuses on how cells in normal tissue surrounding breast tumors naturally produce particles called exosomes that are highly toxic to breast cancer cells, but do not affect non-cancerous cells, the release said.
“Most people develop many cancerous growths over the course of their lifetime,” Trujillo says. “But most of these cancers are eliminated by the human body’s intrinsic cancer protection mechanisms. We believe we have discovered one of these mechanisms and are now developing a new type of cancer drug based on that discovery.”
The New Mexico Start-Up Factory helps bring to market university and national laboratory research technologies.